NovaBridge Biosciences NBP
NASDAQ NBP
$1.36 +0.02 (+1.49%)
At close: Oct 2, 2026 · 4:00 PM EDT

NovaBridge Biosciences (NBP) Non Operating Investment Income (2020 - 2025)

Updated

NovaBridge Biosciences' Non Operating Investment Income came in at -$16,000 for Q3 2025.

Analysis

NovaBridge Biosciences (NBP) Non Operating Investment Income (2020 - 2025) Analysis & Trends

For FY2023, NovaBridge Biosciences' Non Operating Investment Income was -$3.73 million.

  • Going back by year, Non Operating Investment Income was $1.96 million in FY2022, -$4.71 million in FY2021 and -$62.47 million in FY2020.
  • The Q3 2025 figure represents the highest quarterly Non Operating Investment Income since Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 NovaBridge Biosciences 149.78 Mn 149.78 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -16,000.00
Dec 31, 2020 123.01 Mn
API Access

NovaBridge Biosciences Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=NBP&period=max&api_key=YOUR_API_KEY